These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3474079)
1. Ofloxacin therapy of difficult-to-treat infections due to multiresistant organisms. el-Baz W; Osman L; Abd-el-Hamid T; el-Bokl M; Sabbour MS Chemioterapia; 1987 Apr; 6(2):129-33. PubMed ID: 3474079 [TBL] [Abstract][Full Text] [Related]
2. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results]. Altay G; Tulunay C Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736 [TBL] [Abstract][Full Text] [Related]
3. [Clinical study of ofloxacin (OFLX) on urinary tract infections]. Miyata M; Inagaki N; Inada F; Yachiku S; Okamura K; Osanai H; Mizunaga M; Morikawa M Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688 [TBL] [Abstract][Full Text] [Related]
4. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method]. Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684 [TBL] [Abstract][Full Text] [Related]
5. Quinolones for short-term treatment of uncomplicated urinary tract infection. Kadiri S; Ajayi SO; Toki RA East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of complicated urinary tract infections by ofloxacin]. Yoshida K; Takahashi T; Nakame Y; Saitoh H; Negishi T; Horiuchi S; Kaneoya F; Tari K; Satake I; Kojima S Hinyokika Kiyo; 1988 Feb; 34(2):394-401. PubMed ID: 3163876 [TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of ofloxacin against complicated urinary tract infections]. Nishio S; Yoshihara H Hinyokika Kiyo; 1987 Sep; 33(9):1503-7. PubMed ID: 3481217 [TBL] [Abstract][Full Text] [Related]
8. [Sequential parenteral and oral therapy with ofloxacin in urogenital infections]. Presterl E; Bognar H; Winkler S; Thalhammer F; Georgopoulos A; Hoffmann W; Breyer S Wien Med Wochenschr; 1992; 142(17):381-5. PubMed ID: 1481544 [TBL] [Abstract][Full Text] [Related]
9. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects. Naber KG; Bauernfeind A; Dietlein G; Wittenberger R Scand J Urol Nephrol Suppl; 1987; 104():47-57. PubMed ID: 3501901 [TBL] [Abstract][Full Text] [Related]
10. Ofloxacin in the management of complicated urinary tract infections, including prostatitis. Cox CE Am J Med; 1989 Dec; 87(6C):61S-68S. PubMed ID: 2690622 [TBL] [Abstract][Full Text] [Related]
11. [Epidemiology and pathogen spectrum of urinary tract infections]. Breyer S; Feistauer SM; Burgmann H; Georgopoulos M; Georgopoulos A Wien Med Wochenschr; 1991; 141(23-24):533-6. PubMed ID: 1810091 [TBL] [Abstract][Full Text] [Related]
12. Ofloxacin vs. cotrimoxazole in patients with complicated urinary tract infections. Vellucci A; Bernardini G; Battaglia AM; Battaglia P Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):279-81. PubMed ID: 3496284 [TBL] [Abstract][Full Text] [Related]
13. [The study of urinary tract infection with a possible cause of fungi and evaluation of the efficacy of 5-FC]. Suzuki K; Tamai H Hinyokika Kiyo; 1985 Oct; 31(10):1885-94. PubMed ID: 3911766 [TBL] [Abstract][Full Text] [Related]
14. [Personal experience with ofloxacin in patients with resistant urinary tract infections]. Horácková M; Osten J; Potuzník V Vnitr Lek; 1988 Jun; 34(6):545-9. PubMed ID: 3166276 [No Abstract] [Full Text] [Related]
15. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates. Periti P; Mazzei T; Nicoletti P Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081 [TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and therapy of urinary tract infections]. Tauchnitz C Z Gesamte Inn Med; 1992 Sep; 47(9):404-8. PubMed ID: 1441668 [TBL] [Abstract][Full Text] [Related]
18. [Clinical reevaluation of ofloxacin (OFLX) in urinary tract infections]. Akiyama T; Matsuura T; Kurita T Hinyokika Kiyo; 1988 Jan; 34(1):201-4. PubMed ID: 3163875 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. Arslan H; Azap OK; Ergönül O; Timurkaynak F; J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685 [TBL] [Abstract][Full Text] [Related]